CEL-SCIs PRODUCT CANDIDATES CEL-SCI Corporation is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the bodys natural defense system. CEL-SCI is currently focused on the development of the following product candidates and technologies with an emphasis on Multikine: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of cert...
Q2 FY2026 — expected 2026-08-22
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-12-29 | 2025-09-30 | 0001654954-25-014303 | EDGAR | 62K words |
| 2025-01-13 | 2024-09-30 | 0001654954-25-000288 | EDGAR | — |
| 2023-12-21 | 2023-09-30 | 0001654954-23-015877 | EDGAR | — |
| 2022-12-27 | 2022-09-30 | 0001654954-22-016959 | EDGAR | — |
| 2021-12-21 | 2021-09-30 | 0001654954-21-013417 | EDGAR | — |
| 2020-12-29 | 2020-09-30 | 0001654954-20-013975 | EDGAR | — |
| 2019-12-16 | 2019-09-30 | 0001654954-19-013971 | EDGAR | — |
| 2018-12-19 | 2018-09-30 | 0001654954-18-014104 | EDGAR | — |
| 2017-12-29 | 2017-09-30 | 0001654954-17-011928 | EDGAR | — |
| 2016-12-14 | 2016-09-30 | 0001654954-16-004867 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001654954-26-001319 | EDGAR | 17K words |
| 2025-08-14 | 2025-06-30 | 0001654954-25-009568 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001654954-25-005606 | EDGAR | — |
| 2025-02-14 | 2024-12-31 | 0001654954-25-001578 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001654954-24-010651 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001654954-24-006411 | EDGAR | — |
| 2024-02-14 | 2023-12-31 | 0001654954-24-001793 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001654954-23-010485 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001654954-23-006371 | EDGAR | — |
| 2023-02-14 | 2022-12-31 | 0001654954-23-001725 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001654954-22-011196 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001654954-22-006762 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-11-24 | 0001654954-25-013412 | EDGAR | 29K words |
| 2025-11-05 | 0001654954-25-012607 | EDGAR | — |
| 2025-08-29 | 0001654954-25-010184 | EDGAR | — |
| 2025-08-25 | 0001654954-25-009966 | EDGAR | — |
| 2025-07-14 | 0001654954-25-008033 | EDGAR | — |
| 2025-05-23 | 0001654954-25-006091 | EDGAR | — |
| 2025-05-19 | 0001654954-25-005876 | EDGAR | — |
| 2025-03-18 | 0001654954-25-002970 | EDGAR | — |
| 2024-12-31 | 0001654954-24-016019 | EDGAR | — |
| 2024-11-15 | 0001654954-24-014554 | EDGAR | — |
323 total filings indexed. 291 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000725363 |
| Ticker | CVM |
| Exchange | NYSE |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | CO |
| Website | https://www.cel-sci.com |
| Listed | 1983-12-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CVM (~200 tokens, structured JSON with cryptographic provenance)